Currently, leading agencies suggest that BRCA testing could be offered (after genetic counseling) to adults who have blood-related family members with harmful BRCA1/2 gene mutations, have a family history of BRCA-related cancers, or have a personal history that suggests an elevated risk of carrying pathogenic BRCA mutations (including but not limited to: diagnosed breast cancer at a younger age, developed second primary breast cancer, or identified as triple-negative breast cancer) [8,9,10]. This evidence concerns the gene BRCA1 and breast cancer.